A dose-response relationship was seen between physical activity and lower rates of cancer progression and all-cause mortality ...

Denosumab has a greater preventive effect on fractures but an increased risk for MACE compared with oral bisphosphonates.

(HealthDay News) — The US Food and Drug Administration released draft guidelines on Jan. 6 proposing that manufacturers conduct larger, more inclusive studies to ensure pulse oximeters work for people ...